BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2869557)

  • 21. Immunocytochemistry: its evolution and criteria for its application in the study of epon-embedded cells and tissue.
    Gosselin EJ; Cate CC; Pettengill OS; Sorenson GD
    Am J Anat; 1986; 175(2-3):135-60. PubMed ID: 2422914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide hormone production in small cell lung carcinomas with particular reference to gastrin-releasing peptide.
    Yamaguchi K; Abe K; Adachi I; Otsubo K; Nagasaki K; Suzuki M; Maruno K; Asanuma F; Tsuchihashi T; Miyake Y
    Jpn J Clin Oncol; 1986 Sep; 16(3):235-41. PubMed ID: 3022032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors.
    Bostwick DG; Roth KA; Evans CJ; Barchas JD; Bensch KG
    Am J Pathol; 1984 Nov; 117(2):195-200. PubMed ID: 6093543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pattern of ectopic hormone production in lung cancer.
    Bondy PK
    Yale J Biol Med; 1981; 54(3):181-5. PubMed ID: 6270916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical study of pheochromocytomas. An investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, beta-endorphin, and calcitonin in 16 tumors.
    Hassoun J; Monges G; Giraud P; Henry JF; Charpin C; Payan H; Toga M
    Am J Pathol; 1984 Jan; 114(1):56-63. PubMed ID: 6140850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of lysosomes and proteases in hormone secretion and degradation.
    Chertow BS
    Endocr Rev; 1981; 2(2):137-73. PubMed ID: 6117463
    [No Abstract]   [Full Text] [Related]  

  • 28. Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin.
    Springall DR; Ibrahim NB; Rode J; Sharpe MS; Bloom SR; Polak JM
    J Pathol; 1986 Nov; 150(3):151-62. PubMed ID: 3027289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma.
    Hamid QA; Addis BJ; Springall DR; Ibrahim NB; Ghatei MA; Bloom SR; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(2):185-92. PubMed ID: 3037770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide hormone production associated with small cell lung cancer.
    Havemann K; Luster W; Gropp C; Holle R
    Recent Results Cancer Res; 1985; 97():65-76. PubMed ID: 2986246
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation of hormone production in small cell carcinoma of the lung.
    Sorenson GD; Cate CC; Pettengill OS
    Recent Results Cancer Res; 1985; 99():143-56. PubMed ID: 2866568
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical staining of cytocentrifuge prepared cultured cells: nonspecific staining and its elimination.
    Gosselin EJ; Dennett JC; Sorenson GD; Pettengill OS; Cate CC
    Histochem J; 1985 Aug; 17(8):847-58. PubMed ID: 2415484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung tumour cell lines synthesizing peptide hormones established from tumours of four histological types: characterization of the cell lines and analysis of their peptide hormone production.
    Luster W; Gropp C; Kern HF; Havemann K
    Br J Cancer; 1985 Jun; 51(6):865-75. PubMed ID: 2988594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of immunoreactive-polypeptide hormones in cervical carcinoma.
    Inoue T; Yamaguchi K; Suzuki H; Abe K; Chihara T
    Cancer; 1984 Apr; 53(7):1509-14. PubMed ID: 6199101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine pancreatic endocrine tumors: immunohistochemical analysis of hormone content and amyloid.
    O'Brien TD; Hayden DW; O'Leary TP; Caywood DD; Johnson KH
    Vet Pathol; 1987 Jul; 24(4):308-14. PubMed ID: 2887054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
    Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
    Cancer Res; 1994 Feb; 54(3):690-700. PubMed ID: 7905785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectopic hormone production by small cell undifferentiated carcinomas.
    Russell PJ; O'Mara SM; Raghavan D
    Mol Cell Endocrinol; 1990 May; 71(1):1-12. PubMed ID: 2163929
    [No Abstract]   [Full Text] [Related]  

  • 39. Production of biochemical marker substances by bronchogenic carcinomas.
    Merrill WW; Bondy PK
    Clin Chest Med; 1982 May; 3(2):307-20. PubMed ID: 6284436
    [No Abstract]   [Full Text] [Related]  

  • 40. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
    Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
    Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.